HEALTHX NSE filing

Health X Platform Q2 FY27 Earnings Call Transcript Released

The RealCase readHigh impact Positive

Health X Platform reported Q2 FY27 revenue of ₹489 crores, a 59% YoY increase. RetailerShakti grew 60% to ₹429 crores, and SastaSundar grew 39% to ₹55 crores. Gross margins expanded to 8.3%, and EBITDA loss narrowed to 3.5% of revenue. The company launched RetailAir, a mobile-first retail solution, and plans to reach 10% gross margin by FY29.

Why it matters

The announcement includes a detailed discussion of financial performance, strategic initiatives like RetailAir, and future growth plans. The strong revenue growth, margin improvement, and technological advancements are material information for investors, indicating significant developments in the company's business operations and future prospects.

The market read

The company reported strong year-on-year revenue growth, margin expansion, and a narrowed EBITDA loss. The launch of RetailAir and strategic focus on technology and data monetization were highlighted positively. Management's confidence in future growth and profitability, alongside a robust balance sheet, contributes to a positive sentiment.

Health X Platform Limited (formerly Sastasundar Ventures Limited) has released the transcript of its Earnings Conference Call for the second quarter and half-year ended September 30, 2026, of FY2026-27. The call, which took place on November 16, 2026, featured discussions on the company's financial performance, business updates, and strategic direction.

During the call, management highlighted the company's complete ownership and control over its SastaSundar B2C platform, emphasizing that it is fully capitalized with no meaningful debt. The strategy focuses on consolidating India's fragmented medicine distribution market, leveraging data through technology, and expanding into faster-growing healthcare segments like preventive care and wellness. A key point of discussion was the company's commitment to healthcare inclusion, with over 76% of its SastaSundar business and 66% of its RetailerShakti business originating from Tier 2 and Tier 3 India, served profitably within 24 hours for 90% of orders.

Financial performance for Q2 FY27 showed a revenue from operations of ₹489 crores, a 59% year-on-year growth. RetailerShakti contributed ₹429 crores (up 60% YoY), and SastaSundar contributed ₹55 crores (up 39% YoY), marking its sixth consecutive quarter of growth. Gross margins improved to 8.3% from 7.5% in the corresponding quarter last year. The EBITDA loss narrowed to 3.5% of revenue, and the PAT loss improved to 2.6% of revenue. Working capital days reduced to 23 days, with receivables at just 2 days, underscoring the cash-based model.

Technologically, the company launched RetailAir, a mobile-first billing and inventory management solution for retailers, designed to accumulate data and provide intelligence on stock, expiry, and fast movers. This platform aims to improve demand forecasting, inventory placement, and act as a retention and acquisition engine. The company also discussed its investments in AI-embedded value chains, including AI-led picking and sorting in fulfillment centers, and future plans for consumer-facing AI tools and back-end automation. The JITO private label arm has 52 franchise outlets live, with 81 in the pipeline, offering over 1,000 healthcare SKUs.

Filing to action

What to do with a filing like this

Health X Platform Limited filed this with the NSE as a statutory disclosure, categorised under concall transcript released. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.

That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.

See the model portfolios
Primary source

A plain-language summary of a public exchange filing by Health X Platform Limited. Read the original for the full detail.

View original filing